Home
Conditions
Metastatic Melanoma

Clinical trial condition

Metastatic Melanoma

Explore clinical trials studying Metastatic Melanoma. Study availability and eligibility vary by location and protocol.

228 public trials 41 recruiting studies

Refine in advanced search Browse all conditions

Metastatic Melanoma trial results

Recruiting

Biomarkers in Immunotherapy of Melanoma

NCT05878977

Conditions: Exosomal mRNA Expression of PD-L1 and IFNγ, Gastrointestinal Microbiome (Bacterial and Viral), Immune Checkpoints Inhibitors, +13 more
Locations: Institute of Oncology Ljubljana Ljubljana, Slovenia

View Trial Details

Enrolling by Invitation

A Trial of AK104 or AK112 in Combination With Axitinib in Patients With Metastatic Mucosal Melanoma

NCT06424626

Conditions: Melanoma, Metastatic Melanoma, Mucosal Melanoma, +11 more
Locations: Beijing Cancer Hospital Beijing, China

View Trial Details

Not Yet Recruiting

A Study To Assess the Safety, and Tolerability of Nivolumab + Relatlimab Fixed-Dose Combination (FDC) In Untreated, Unresectable or Metastatic Melanoma Participants In India

NCT07459543

Conditions: Melanoma, Metastatic Melanoma, Neoplasms, +12 more
Locations: Local Institution - 0009 Navi Mumbai, Maharashtra, India

Local Institution - 0008 Pune, Maharashtra, India

Local Institution - 0003 Bhubaneswar, Odisha, India

Local Institution - 0002 Chennai, India

View Trial Details

Not Yet Recruiting

Power of Liquid Biopsy Tracking in Immunotherapy Treated Stage IV Melanoma

NCT06710093

Conditions: Melanoma, Metastatic Melanoma, Neoplasms, +10 more
Locations: The Royal Marsden Chelsea, London, United Kingdom

View Trial Details

Completed

Nivolumab +/- Ipilimumab Immunomonitoring in Metastatic Melanoma

NCT03225365

Conditions: Melanoma, Metastatic Melanoma, Neoplasms, +10 more
Locations: Service de Dermatologie, Centre Hospitalier Lyon Sud (HCL) Pierre-Bénite, France

View Trial Details

Completed

Study of IDO Inhibitor in Combination With Checkpoint Inhibitors for Adult Patients With Metastatic Melanoma

NCT02073123

Conditions: Melanoma, Metastatic Melanoma, Neoplasms, +12 more
Locations: Augusta University Augusta, Georgia, United States

University of Iowa Hospital and Clinics Iowa City, Iowa, United States

Mayo Clinic Rochester, Minnesota, United States

New Mexico Cancer Center Alliance Albuquerque, New Mexico, United States

View Trial Details

Completed

Lifileucel With Reduced Dose Fludarabine/Cyclophosphamide Lymphodepletion and Interleukin-2 for the Treatment of Patients With Unresectable or Metastatic Melanoma

NCT06151847

Conditions: Clinical Stage IV Cutaneous Melanoma AJCC v8, Melanoma, Metastatic Melanoma, +13 more
Locations: University of Kansas Cancer Center Kansas City, Kansas, United States

View Trial Details

Completed

Pilot Study of Nivolumab w/Ipilimumab or Relatlimab in Surgically Resectable Melanoma Brain Metastases

NCT05704933

Conditions: Brain Diseases, Brain Neoplasms, Central Nervous System Diseases, +17 more
Locations: Moffitt Cancer Center Tampa, Florida, United States

M.D. Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Study of Oral Azacitidine (CC-486) in Combination With Pembrolizumab (MK-3475) in Patients With Metastatic Melanoma

NCT02816021

Conditions: Melanoma, Melanoma and Other Malignant Neoplasms of Skin, Metastatic Melanoma, +11 more
Locations: University of Texas MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Proof of Concept of TBio-4101, Lymphodepleting Chemo, IL-2 for Relapsed/Refractory Melanoma

NCT05628883

Conditions: Acral Melanoma, Conjunctival Melanoma, Cutaneous Melanoma, +23 more
Locations: Moffitt Cancer Center Tampa, Florida, United States

View Trial Details

Metastatic Melanoma

Metastatic Melanoma trial results

Related conditions